Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Recurrence/metastasis</td><td class="align_center">Death</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Breast cancer stages I-II group (<i>n</i> = 54)</td><td class="align_center">16 (29.63)</td><td class="align_center">6 (11.11)</td></tr><tr><td class="align_left">Breast cancer stages III-IV group (<i>n</i> = 42)</td><td class="align_center">22 (40.74)</td><td class="align_center">15 (27.78)</td></tr><tr><td class="align_left"><i>x</i><sup>2</sup></td><td class="align_center">5.113</td><td class="align_center">8.368</td></tr><tr><td class="align_left"><i>P</i></td><td class="align_center">0.024</td><td class="align_center">0.004</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Prognosis of breast cancer patients in different groups at 12 months (<i>n</i>, %).</div>

Contrast Media & Molecular Imaging

tab6

Table 6

Table 6: Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis 

Table 6 | Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis 